Familial erythrophagocytic lymphohistiocytosis (FEL) is a rare and fatal hereditary disorder of unknown cause with multisystem involvement. Involvement of the central nervous system (CNS) is reported in approximately 30% of cases. Leptomeningitis, gliosis, demyelination, and lymphocyte and histiocyte infiltration of the cerebrum and cerebellum are the characteristic neuropathologic findings. We describe the serial brain MRI findings and neurologic symptoms in a case of FEL, and review the literature.
Case ReportA 16-month-old male was transferred to our hospital due to dyspnea, tachypnea, fever, and aggravated abdominal distention, present for one week. He had previously been admitted to another hospital, with similar symptoms, five months earlier. His first and third older female siblings died at two months and two years of age, respectively of fever of unknown origin and hepatosplenomegaly. The second male sibling, eight years old, is currently alive.Physical examination revealed hepatosplenomegaly, shifting dullness, anemic conjunctiva, and jaundice, and hematological study showed pancytopenia, hypofibrinogenemia, and hyperferritinemia : Hb, 6.1 g/dl; WBC, Familial erythrophagocytic lymphohistiocytosis is a fatal early childhood disorder characterized by multiorgan lymphohistiocytic infiltration and active hemophagocytosis. Involvement of the central nervous system (CNS) is not uncommon and is characterized by rapidly progressive tissue damage affecting both the gray and white matter. We encountered a case of familial erythrophagocytic lymphohistiocytosis with CNS involvement. Initial T2-weighted MRI of the brain demonstrated high signal intensity in the right thalamus, though after chemotherapy, which led to the relief of neurologic symptoms, this disappeared. After four months, however, the patient s neurologic symptoms recurred, and follow-up T2-weighted MR images showed high signal intensity in the thalami, basal ganglia, and cerebral and cerebellar white matter.Brain MRI is a useful imaging modality for the evaluation of CNS involvement and monitoring the response to treatment.